<DOC>
	<DOCNO>NCT01895582</DOCNO>
	<brief_summary>Background : Diagnosis screen latent tuberculosis old patient special interest regard morbidity-mortality disease context . TB-infection diagnosis base immunological memory detection impaired age . New blood test ( QFTB-G T-SPOT.TB ) specific MTB infection evaluate old patients.The primary endpoint study evaluation IGRAS active TB diagnosis patient 75 year old .</brief_summary>
	<brief_title>Performance IGRAs TB Infection Diagnosis Elderly</brief_title>
	<detailed_description>In vitro Interferon Gamma release Assay ( IGRA ) recommend LTBI screen instead TST , accuracy old patient know : immune response impair elderly already meet M tuberculosis active antibiotherapy exists.The aim study evaluate characteristic two commercial test IGRA T-spot-TB® Quantiferon-TB-gold- tube® TST old patient without active Tuberculosis . Principal outcome : - 3 test performance active TB diagnosis patient older 75 years-old Secondary outcome : - concordance IGRAs . - non-concordant result analysis - concordance IGRAs result time TB-infection - biobank Methodology : Diagnostic test performance study</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-gamma</mesh_term>
	<criteria>Age &gt; 75 year , birth 1935 Consent sign Inpatient 1st Phase ( till recruitment 80 patient group 2 ) : patient test active TB perform Second Phase ( 1st phase ) : patient treat active TB French social right Tuberculosis disease treatment since 7 day No 3 month followup possible Immunosuppression</criteria>
	<gender>All</gender>
	<minimum_age>75 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Ageing</keyword>
	<keyword>Tuberculosis</keyword>
	<keyword>Interferon gamma releasing test</keyword>
</DOC>